Likewise, a combination of the intraoperative usage of DEX and postoperative IVPCA of DEX and ketorolac could provide adequate postoperative analgesia, reduce opioid consumption and relative complications, and alleviate immunosuppression and inflammation with a decrease in the serum TNF-α level in patients with lung cancer undergoing thoracoscopic surgery [108]. Here, TNF is linked to lung cancer.